GLP-1-based therapies for obesity have been transformational. The benefits are undeniable, and the risks for most people are negligible. These drugs belong in the class with anti-hypertensives and statins. Who could complain? Here’s one doc who was an initial enthusiast, but who has cooled: “The truth is, most patients don’t stay on anti-obesity medications — […]

Personally, I’ve never had a weight problem. Always had a BMI under 24. But I’ve known plenty of people who were overweight or obese. For the ones who started taking semaglutides, the results have been transformative and the risks for most have been negligible. But don’t take my word for it. Here’s Dr. McGowan, a […]